Search for: "Lupin Pharmaceuticals"
Results 101 - 120
of 175
Sort by Relevance
|
Sort by Date
22 Jun 2010, 9:45 pm
Lupin Pharmaceuticals, Inc., the Federal Circuit completed the hat trick of patent term extension cases with Wyeth Holdings Corp. v. [read post]
3 Jun 2010, 5:42 pm
Lupin Pharmaceuticals, Inc. [read post]
28 May 2010, 9:30 am
Lupin Pharmaceuticals Inc., No. 2009-1362 (Fed. [read post]
27 May 2010, 3:20 am
Lupin Ltd. [read post]
19 May 2010, 10:48 am
The district court then enjoined Lupin Pharmaceuticals from infringement during the extended term of the patent. [read post]
19 May 2010, 6:15 am
Lupin Pharmaceuticals, Inc. [read post]
16 May 2010, 9:59 pm
Lupin Pharmaceuticals, Inc., the Federal Circuit has rendered a decision on the question of whether separate enantiomers can have "first commercial marketing or use" status for purposes of patent term extension under 35 U.S.C. [read post]
13 May 2010, 4:58 pm
Lupin; Photocure v. [read post]
10 May 2010, 11:26 am
" Lupin challenged the PTO's granting an extension to 5,053,407, "an enantiomer of a racemic compound that had previously been approved by the Food and Drug Administration (FDA)," to no avail. [read post]
10 May 2010, 10:37 am
Lupin Pharmaceuticals, Inc. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
24 Mar 2010, 4:45 am
Lupin Ltd. et al. [read post]
21 Mar 2010, 9:55 pm
Lupin Ltd. et al. 1:10-cv-00661; filed March 17, 2010 in the District Court of Maryland • Plaintiffs: Cephalon, Inc.; Cephalon France • Defendants: Lupin Ltd.; Lupin Pharmaceuticals, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in… [read post]
23 Feb 2010, 9:01 pm
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
21 Feb 2010, 8:25 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals, Inc. [read post]
17 Feb 2010, 8:00 am
Lupin Ltd. and Lupin Pharmaceuticals Inc. [read post]
